Hanmi Pharm. Co., Ltd. (KRX:128940)
299,000
+3,000 (1.01%)
At close: Sep 15, 2025
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 3.79 trillion as of September 15, 2025. Its market cap has increased by 3.46% in one year.
Market Cap
3.79T
Enterprise Value
4.19T
Revenue
1.47T
Ranking
n/a
PE Ratio
35.32
Stock Price
299,000.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 3.79T, an increase of 456.98%. That is a compound annual growth rate of 12.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 3,791.38B | 6.60% |
Dec 30, 2024 | 3,556.80B | -20.49% |
Dec 28, 2023 | 4,473.42B | 20.54% |
Dec 29, 2022 | 3,711.17B | 10.00% |
Dec 30, 2021 | 3,373.87B | -23.27% |
Dec 30, 2020 | 4,397.24B | 25.97% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.88T |
Celltrion | 37.82T |
ALTEOGEN | 26.27T |
Yuhan | 8,955.07B |
SK Biopharmaceuticals | 8,692.77B |
Peptron | 7,152.29B |
PharmaResearch | 6,690.93B |
ABL Bio | 5,746.76B |